CU24319B1 - QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS - Google Patents

QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS

Info

Publication number
CU24319B1
CU24319B1 CUP2015000028A CU20150028A CU24319B1 CU 24319 B1 CU24319 B1 CU 24319B1 CU P2015000028 A CUP2015000028 A CU P2015000028A CU 20150028 A CU20150028 A CU 20150028A CU 24319 B1 CU24319 B1 CU 24319B1
Authority
CU
Cuba
Prior art keywords
derived
formula
amina
quinolin
quinoxaline
Prior art date
Application number
CUP2015000028A
Other languages
English (en)
Other versions
CU20150028A7 (es
Inventor
Florence Mahuteau
Romain Najman
Jamal Tazi
Original Assignee
Abivax
Centre Nat Rech Scient
Inst Curie
Univ Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20090305540 external-priority patent/EP2266972A1/en
Application filed by Abivax, Centre Nat Rech Scient, Inst Curie, Univ Montpellier filed Critical Abivax
Priority claimed from PCT/IB2010/052652 external-priority patent/WO2010143170A2/en
Publication of CU20150028A7 publication Critical patent/CU20150028A7/es
Publication of CU24319B1 publication Critical patent/CU24319B1/es

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<p>Un compuesto de fórmula (I) o sales farmacéuticamente aceptables de los mismos, donde las sales farmacéuticamente aceptables son seleccionadas de hidrobromada, tartrato, citrato, trifluoroacetato, ascorbato, hidroclorido, tartrato, triflato, maleato, mesilato, formato, acetato y fumarato El cual es alternativamente seleccionado de entre un compuesto de fórmula Ik y un compuesto Ip.</p>
CUP2015000028A 2009-06-12 2010-06-14 QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS CU24319B1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18654409P 2009-06-12 2009-06-12
EP20090305540 EP2266972A1 (en) 2009-06-12 2009-06-12 New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies
PCT/IB2010/052652 WO2010143170A2 (en) 2009-06-12 2010-06-14 Compounds useful for treating premature aging and in particular progeria

Publications (2)

Publication Number Publication Date
CU20150028A7 CU20150028A7 (es) 2015-11-27
CU24319B1 true CU24319B1 (es) 2018-02-08

Family

ID=55659614

Family Applications (3)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (es) 2009-06-12 2010-06-14 QUINOLIN Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ii), (Ij), (Ij'), (Ij'') y (Ij''') Y SALES DERIVADAS
CUP2015000028A CU24319B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS
CUP2015000025A CU24322B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVADOS DE LA FÓRMULA (Ig) Y SALES DERIVADAS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (es) 2009-06-12 2010-06-14 QUINOLIN Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ii), (Ij), (Ij'), (Ij'') y (Ij''') Y SALES DERIVADAS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CUP2015000025A CU24322B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVADOS DE LA FÓRMULA (Ig) Y SALES DERIVADAS

Country Status (1)

Country Link
CU (3) CU24323B1 (es)

Also Published As

Publication number Publication date
CU24322B1 (es) 2018-02-08
CU20150028A7 (es) 2015-11-27
CU20150025A7 (es) 2015-11-27
CU20150027A7 (es) 2015-11-27
CU24323B1 (es) 2018-02-08

Similar Documents

Publication Publication Date Title
CU24461B1 (es) Compuestos útiles para tratar envejecimiento prematuro y en particular progeria
NL301202I1 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
CY1124219T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τοπικο αναiσθητiκο οπως η βουπιβακαϊνη για τοπικη χορηγηση στο στομα ή τον φαρυγγα
DE602004016127D1 (de) Antagonisten der opioidrezeptoren
NO20091395L (no) Nye tiofenderivater
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
ATE519764T1 (de) Spiroindolinon-derivate
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
WO2008005368A3 (en) Piperazines as p2x7 antagonists
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
ATE446962T1 (de) Thiazolopyridinon-derivate als mch- rezeptorantagonisten
ME02558B (me) Inhibitori replikacije virusa gripa
EP2246051A4 (en) METHOD FOR PRODUCING A RASCH IN THE MOUTH-DISKING TABLET WITH IMIDAFENACIN AS AN ACTIVE SUBSTANCE
JP2013519683A5 (es)
EA201390717A1 (ru) 3-(аминоарил)пиридиновые соединения
MX2009004662A (es) Compuestos de pirazolina como antagonistas receptores de mineralocorticoides.
MA32812B1 (fr) Composition pharmaceutique d&#39;un inhibiteur puissant du vhc pour une administration orale
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
EA201190034A1 (ru) Полиморфы (s)-3-аминометил-7-(3-гидроксипропокси)-3н-бензо[c][1,2]оксаборол-1-ола
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
UA107919C2 (en) Anti-wrinkle means